Aclaris Therapeutics Inc (ACRS)
3.31
-1.49%
Aclaris Therapeutics Inc (ACRS) is currently trading at $3.31. This represents a loss of 1.49% from the previous session. With a market capitalization of $0.36B, ACRS is a key component of the Health Care sector. Investors looking to trade ACRS should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade ACRS commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Aclaris Therapeutics Inc (ACRS) shows a bearish trend. Analysts are watching the 3.42 level closely.
Fundamentals
Mkt Cap0.36B
P/E Ratio0.0000
Volume1,035,460
60-Day Technical Chart
Advanced Charting
Need more indicators for ACRS? Use the world's #1 platform.
Open ACRS on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $3
| Metric |
ACRS -1.49% |
MNKD -36.82% |
IRWD -11.35% |
EVH +22.66% |
|---|---|---|---|---|
| Price | $3.31 | $3.50 | $3.36 | $3.14 |
| Mkt Cap | $0.36B | $1.07B | $0.55B | $0.35B |
| - | View → | View → | View → |
Latest Headlines
Aclaris tests experimental asthma antibody in new human trial
Stock Titan • Feb 24, 2026
There's Reason For Concern Over Aclaris Therapeutics, Inc.'s (NASDAQ:ACRS) Massive 25% Price Jump
simplywall.st • Feb 3, 2026
What Makes Aclaris Therapeutics (ACRS) a Strong Momentum Stock: Buy Now?
Yahoo Finance • Oct 21, 2025
Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)
GlobeNewswire • Dec 19, 2025
HC Wainwright & Co. Reiterates Aclaris Therapeutics (ACRS) Buy Recommendation
Nasdaq • Oct 20, 2025
● Gemini Agentic AI Analyst Insight for ACRS
Market Education
- Are Cruise Stocks Finally Back on Course After a Rocky Five Years? Sep 27, 2025
- Stocks with Cash and Low Debt Dec 10, 2023
- I want to day trade, which technical analysis indicators work best. Jul 15, 2023
External Research